• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Candida norvegensis: a fluconazole-resistant species.挪威念珠菌：一种耐氟康唑的菌种。
Antimicrob Agents Chemother. 1997 Jun;41(6):1375-6. doi: 10.1128/AAC.41.6.1375.
2
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.念珠菌属对氟康唑耐药的临床分离株对棘白菌素LY303366、伊曲康唑和两性霉素B的敏感性。
J Antimicrob Chemother. 2000 Sep;46(3):475-7. doi: 10.1093/jac/46.3.475.
3
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.韩国 15 家三级医院血源分离株念珠菌对两性霉素 B、氟康唑、伏立康唑和氟胞嘧啶的药敏性
Ann Lab Med. 2012 Nov;32(6):426-8. doi: 10.3343/alm.2012.32.6.426. Epub 2012 Oct 17.
4
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.念珠菌属和新型隐球菌抗真菌药敏试验的Etest法多中心评估。英国抗菌化疗学会工作组
J Antimicrob Chemother. 1998 Sep;42(3):321-31. doi: 10.1093/jac/42.3.321.
5
In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital.卡泊芬净与两性霉素B、氟康唑和伊曲康唑相比，对土耳其一家大学医院分离出的念珠菌菌株的体外活性。
Med Mycol. 2005 Mar;43(2):171-8. doi: 10.1080/13693780410001731565.
6
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.五种抗真菌剂对念珠菌属罕见临床分离株的体外活性
J Antimicrob Chemother. 1999 Feb;43(2):295-9. doi: 10.1093/jac/43.2.295.
7
In vitro susceptibility of Candida dubliniensis to current and new antifungal agents.都柏林念珠菌对现有及新型抗真菌药物的体外敏感性
Chemotherapy. 2000 Nov-Dec;46(6):395-401. doi: 10.1159/000007320.
8
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].[委内瑞拉马拉开波市一家大学医院血培养分离出的念珠菌属的抗真菌药敏概况]
Rev Iberoam Micol. 2006 Jun;23(2):97-100. doi: 10.1016/s1130-1406(06)70022-5.
9
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].伏立康唑及其他抗真菌药物对138株念珠菌临床分离株的体外活性
Infez Med. 2009 Mar;17(1):24-7.
10
In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.545株念珠菌属菌株对四种抗真菌药物的体外敏感性
Mycoses. 1994 Jul-Aug;37(7-8):285-9. doi: 10.1111/j.1439-0507.1994.tb00428.x.

引用本文的文献

1
A Repertoire of the Less Common Clinical Yeasts.罕见临床酵母菌名录
J Fungi (Basel). 2023 Nov 11;9(11):1099. doi: 10.3390/jof9111099.
2
Overview on the Infections Related to Rare Species.稀有物种相关感染概述
Pathogens. 2022 Aug 24;11(9):963. doi: 10.3390/pathogens11090963.
3
Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries.21 重聚合酶链反应与 API 20C AUX、MALDI-TOF MS 和 rDNA 测序对广泛临床分离酵母种的比较：通过将 21 重聚合酶链反应与 API 20C AUX 相结合作为发展中国家的替代策略，提高鉴定能力。
Front Cell Infect Microbiol. 2019 Feb 15;9:21. doi: 10.3389/fcimb.2019.00021. eCollection 2019.
4
Growth of Candida norvegensis (strain Levazoot 15) with different energy, nitrogen, vitamin, and micromineral sources.挪威假丝酵母（Levazoot 15 株）在不同能量、氮源、维生素和微量元素来源下的生长情况。
Braz J Microbiol. 2019 Apr;50(2):533-537. doi: 10.1007/s42770-018-0015-4. Epub 2018 Nov 29.
5
Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review.肝移植患者中由挪威念珠菌引起的侵袭性念珠菌病：病例报告及文献综述
Infect Dis Rep. 2014 Jun 24;6(2):5374. doi: 10.4081/idr.2014.5374. eCollection 2014 May 13.
6
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.ARTEMIS DISK 全球抗真菌监测研究结果，1997 年至 2007 年：10.5 年时间内通过 CLSI 标准化纸片扩散法测定的念珠菌属对氟康唑和伏立康唑的药敏性分析。
J Clin Microbiol. 2010 Apr;48(4):1366-77. doi: 10.1128/JCM.02117-09. Epub 2010 Feb 17.
7
Epidemiology of invasive candidiasis: a persistent public health problem.侵袭性念珠菌病的流行病学：一个持续存在的公共卫生问题。
Clin Microbiol Rev. 2007 Jan;20(1):133-63. doi: 10.1128/CMR.00029-06.
8
Candidemia in Norway (1991 to 2003): results from a nationwide study.挪威念珠菌血症（1991年至2003年）：一项全国性研究的结果
J Clin Microbiol. 2006 Jun;44(6):1977-81. doi: 10.1128/JCM.00029-06.
9
Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures.核糖体DNA的限制性内切酶分析表明，使用传统诊断方法， inconspicua念珠菌临床分离株可能会被误鉴定为挪威念珠菌。
J Clin Microbiol. 2003 Nov;41(11):5250-3. doi: 10.1128/JCM.41.11.5250-5253.2003.
10
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.导致抗真菌药物耐药性的临床、细胞和分子因素。
Clin Microbiol Rev. 1998 Apr;11(2):382-402. doi: 10.1128/CMR.11.2.382.

本文引用的文献

1
[Study of a Norwegian collection of yeasts].
Ann Parasitol Hum Comp. 1954;29(4):460-98; concl.
2
Standardization of antifungal susceptibility testing.抗真菌药敏试验的标准化
J Antimicrob Chemother. 1996 Oct;38(4):561-78. doi: 10.1093/jac/38.4.561.
3
Isolation of Candida norvegensis from clinical specimens: four case reports.从临床标本中分离出挪威念珠菌：4例病例报告
Clin Infect Dis. 1996 Nov;23(5):1185-7. doi: 10.1093/clinids/23.5.1185.
4
Invasive Candida norvegensis infection in immunocompromised patients.
Scand J Infect Dis. 1996;28(3):311-2. doi: 10.3109/00365549609027180.
5
Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.一种用于酵母分离株抗真菌药敏试验的新型比色肉汤微量稀释法的评估。
J Clin Microbiol. 1994 Aug;32(8):1992-6. doi: 10.1128/jcm.32.8.1992-1996.1994.
6
Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.一名持续非卧床腹膜透析患者发生挪威念珠菌腹膜炎及侵袭性疾病。
J Clin Microbiol. 1990 Jul;28(7):1664-5. doi: 10.1128/jcm.28.7.1664-1665.1990.

挪威念珠菌：一种耐氟康唑的菌种。

Candida norvegensis: a fluconazole-resistant species.

作者信息

Sandven P, Nilsen K, Digranes A, Tjade T, Lassen J

机构信息

Department of Bacteriology, National Institute of Public Health, Oslo, Norway.

出版信息

Antimicrob Agents Chemother. 1997 Jun;41(6):1375-6. doi: 10.1128/AAC.41.6.1375.

DOI:10.1128/AAC.41.6.1375
PMID:9174202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163918/
Abstract

Candida norvegensis has been an unusual cause of infections in humans. In Norway this species was isolated from eight patients from 1990 to 1996 and was of probable pathogenic significance in four of them. All isolates were resistant to fluconazole. The same was true for two C. norvegensis isolates from before 1940, and it is therefore assumed that the fluconazole resistance is inherent.

摘要

挪威念珠菌一直是人类感染的不寻常病因。在挪威，1990年至1996年期间从8名患者中分离出该菌种，其中4例可能具有致病意义。所有分离株均对氟康唑耐药。1940年前分离出的两株挪威念珠菌也是如此，因此推测氟康唑耐药性是其固有特性。